omega-n-methylarginine has been researched along with natriuretic peptide, brain in 7 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (natriuretic peptide, brain) | Trials (natriuretic peptide, brain) | Recent Studies (post-2010) (natriuretic peptide, brain) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 16,317 | 1,867 | 8,887 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | natriuretic peptide, brain (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 1 | Homo sapiens (human) | 0.006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, U; Shimada, K; Yamamoto, K | 1 |
| Hashimoto, M; Inoue, S; Ishibashi, Y; Katoh, H; Murakami, Y; Ohhata, S; Sakane, T; Sano, K; Shimada, T; Sugamori, T; Takahashi, N | 1 |
| Hashimoto, M; Inoue, S; Ishibashi, Y; Katoh, H; Murakami, Y; Nakamura, K; Ohata, S; Ohta, Y; Sakane, T; Shimada, T; Shimizu, H; Sugamori, T; Takahashi, N | 1 |
| de Leeuw, PW; De Mey, JG; Houben, AJ; Kroon, AA; Smits, PA; van der Zander, K | 1 |
| Broadley, AJ; Cockcroft, JR; Frenneaux, MP; Gunaruwan, P; Lee, L; Nightingale, AK; Payne, N; Schmitt, M; Struthers, AD; Taylor, J; Tyberg, JV | 1 |
| Bech, JN; Nielsen, EH; Pedersen, EB; Pedersen, RS; Svendsen, KB | 1 |
| Bech, JN; Hansen, AB; Jensen, JM; Larsen, T; Mose, FH; Pedersen, EB | 1 |
2 trial(s) available for omega-n-methylarginine and natriuretic peptide, brain
| Article | Year |
|---|---|
Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
Topics: Administration, Oral; Adult; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Cyclic GMP; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Lithium; Male; Middle Aged; Natriuresis; Natriuretic Peptide, Brain; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Renal Circulation; Renin-Angiotensin System; Sodium; Sodium Chloride; Time Factors | 2007 |
Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes.
Topics: Aged; Arginine Vasopressin; Atorvastatin; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Tubules; Male; Middle Aged; Natriuretic Peptide, Brain; Nitric Oxide; omega-N-Methylarginine; Pulse Wave Analysis; Pyrroles; Renal Insufficiency, Chronic; Treatment Outcome; Vascular Stiffness; Vasopressins | 2014 |
5 other study(ies) available for omega-n-methylarginine and natriuretic peptide, brain
| Article | Year |
|---|---|
Natriuretic peptides modulate nitric oxide synthesis in cytokine-stimulated cardiac myocytes.
Topics: Animals; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Heart; Interleukin-1; Myocardium; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Protein Kinases; Proteins; Rats; Rats, Sprague-Dawley | 1997 |
Contribution of endogenous nitric oxide to basal vasomotor tone of peripheral vessels and plasma B-type natriuretic peptide levels in patients with congestive heart failure.
Topics: Adult; Aged; Atrial Natriuretic Factor; Enzyme Inhibitors; Female; Heart Failure; Humans; Male; Middle Aged; Muscle Tonus; Natriuretic Peptide, Brain; Nitric Oxide; omega-N-Methylarginine; Regional Blood Flow; Severity of Illness Index; Vasomotor System | 2000 |
An inhibitor of inducible nitric oxide synthase decreases forearm blood flow in patients with congestive heart failure.
Topics: Acetylcholine; Adult; Aged; Analysis of Variance; Atrial Natriuretic Factor; Blood Flow Velocity; Case-Control Studies; Disease Progression; Dose-Response Relationship, Drug; Drug Monitoring; Endothelium, Vascular; Female; Forearm; Guanidines; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Plethysmography; Severity of Illness Index; Time Factors; Vasodilation | 2001 |
Nitric oxide and potassium channels are involved in brain natriuretic peptide induced vasodilatation in man.
Topics: Adult; Cyclic GMP; Drug Combinations; Enzyme Inhibitors; Forearm; Humans; Male; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nitric Oxide; omega-N-Methylarginine; Potassium Channel Blockers; Potassium Channels; Regional Blood Flow; Tetraethylammonium; Vasodilation; Vasodilator Agents | 2002 |
Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Arteries; Atrial Natriuretic Factor; Cardiovascular Agents; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Heart Failure; Humans; Injections, Intra-Arterial; Male; Middle Aged; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Natriuretic Peptides; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Peptide Fragments; Tetrahydroisoquinolines; Vascular Resistance; Vasodilation; Veins | 2004 |